1. Home
  2. SONN vs ANGH Comparison

SONN vs ANGH Comparison

Compare SONN & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • ANGH
  • Stock Information
  • Founded
  • SONN N/A
  • ANGH 2012
  • Country
  • SONN United States
  • ANGH United Arab Emirates
  • Employees
  • SONN N/A
  • ANGH N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • ANGH Telecommunications Equipment
  • Sector
  • SONN Health Care
  • ANGH Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • ANGH Nasdaq
  • Market Cap
  • SONN 21.4M
  • ANGH 19.7M
  • IPO Year
  • SONN N/A
  • ANGH N/A
  • Fundamental
  • Price
  • SONN $4.46
  • ANGH $2.83
  • Analyst Decision
  • SONN Strong Buy
  • ANGH
  • Analyst Count
  • SONN 1
  • ANGH 0
  • Target Price
  • SONN $20.00
  • ANGH N/A
  • AVG Volume (30 Days)
  • SONN 1.1M
  • ANGH 9.0K
  • Earning Date
  • SONN 08-13-2025
  • ANGH 10-24-2025
  • Dividend Yield
  • SONN N/A
  • ANGH N/A
  • EPS Growth
  • SONN N/A
  • ANGH N/A
  • EPS
  • SONN N/A
  • ANGH N/A
  • Revenue
  • SONN $1,000,000.00
  • ANGH $78,093,405.00
  • Revenue This Year
  • SONN $5,376.22
  • ANGH N/A
  • Revenue Next Year
  • SONN N/A
  • ANGH N/A
  • P/E Ratio
  • SONN N/A
  • ANGH N/A
  • Revenue Growth
  • SONN 1689.52
  • ANGH 88.72
  • 52 Week Low
  • SONN $1.08
  • ANGH $2.53
  • 52 Week High
  • SONN $19.30
  • ANGH $9.40
  • Technical
  • Relative Strength Index (RSI)
  • SONN 44.44
  • ANGH 41.50
  • Support Level
  • SONN $4.25
  • ANGH $2.92
  • Resistance Level
  • SONN $6.15
  • ANGH $3.10
  • Average True Range (ATR)
  • SONN 0.64
  • ANGH 0.11
  • MACD
  • SONN -0.21
  • ANGH -0.02
  • Stochastic Oscillator
  • SONN 9.90
  • ANGH 22.69

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

Share on Social Networks: